2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole

C27H16N10OS — CID 54550762

IUPAC2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole
SMILESc1cnc(-c2cccnc2-c2coc(-c3ccsc3-c3nncc(-c4cnccn4)c3-c3ncc[nH]3)n2)nc1
InChIInChI=1S/C27H16N10OS/c1-3-16(25-31-6-2-7-32-25)22(30-5-1)20-15-38-27(36-20)17-4-12-39-24(17)23-21(26-33-10-11-34-26)18(13-35-37-23)19-14-28-8-9-29-19/h1-15H,(H,33,34)
InChIKeyMNYKVPXTEMOUKU-UHFFFAOYSA-N
MW528.56 g/mol
LogP5.23
Rot. Bonds6

About 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole

2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole (PubChem CID 54550762) has the molecular formula C27H16N10OS and a molecular weight of 528.56 g/mol. Its IUPAC name is 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole.

Molecular Properties

Compound Name2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole
PubChem CID54550762
Molecular FormulaC27H16N10OS
Molecular Weight528.56 g/mol
Exact Mass528.12
IUPAC Name2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole
SMILESc1cnc(-c2cccnc2-c2coc(-c3ccsc3-c3nncc(-c4cnccn4)c3-c3ncc[nH]3)n2)nc1
InChIInChI=1S/C27H16N10OS/c1-3-16(25-31-6-2-7-32-25)22(30-5-1)20-15-38-27(36-20)17-4-12-39-24(17)23-21(26-33-10-11-34-26)18(13-35-37-23)19-14-28-8-9-29-19/h1-15H,(H,33,34)
InChIKeyMNYKVPXTEMOUKU-UHFFFAOYSA-N
XLogP5.23
TPSA144.94 Ų
H-Bond Donors1
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms39
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500528.56
LogP ≤ 55.23
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1011

Analyze 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole?
The IUPAC name of 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole (CID 54550762) is 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole.
What is the SMILES notation for 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole?
The canonical SMILES for 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole is c1cnc(-c2cccnc2-c2coc(-c3ccsc3-c3nncc(-c4cnccn4)c3-c3ncc[nH]3)n2)nc1.
What is the InChIKey of 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole?
The InChIKey is MNYKVPXTEMOUKU-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H16N10OS/c1-3-16(25-31-6-2-7-32-25)22(30-5-1)20-15-38-27(36-20)17-4-12-39-24(17)23-21(26-33-10-11-34-26)18(13-35-37-23)19-14-28-8-9-29-19/h1-15H,(H,33,34).
What are the key properties of 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole?
2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole has a molecular weight of 528.56 g/mol, XLogP of 5.23, 6 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[4-(1H-imidazol-2-yl)-5-pyrazin-2-ylpyridazin-3-yl]thiophen-3-yl]-4-(3-pyrimidin-2-yl-2-pyridinyl)-1,3-oxazole is sourced from PubChem (CID 54550762), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).